1. Koren G, Clark S, Hankins GD V, Caritis SN, Umans JG, Miodovnik M, et al. Maternal safety of the delayed-release doxylamine and pyridoxine combination for nausea and vomiting of pregnancy; a randomized placebo controlled trial. BMC Pregnancy Childbirth 2015;15:59. [ DOI:10.1186/s12884-015-0488-1] 2. Lee NM, Saha S. Nausea and vomiting of pregnancy. Gastroenterol Clin 2011;40:309-34. [ DOI:10.1016/j.gtc.2011.03.009] 3. Madjunkova S, Maltepe C, Koren G. The Delayed-Release Combination of Doxylamine and Pyridoxine (Diclegis®/Diclectin®) for the Treatment of Nausea and Vomiting of Pregnancy. Pediatr Drugs 2014;16:199-211. [ DOI:10.1007/s40272-014-0065-5] 4. Matthews A, Haas DM, O'Mathúna DP, Dowswell T. Interventions for nausea and vomiting in early pregnancy. Cochrane Database Syst Rev 2015:1-96. [ DOI:10.1002/14651858.CD007575.pub4] 5. Ashkenazi-Hoffnung L, Merlob P, Stahl B, Klinger G. Evaluation of the efficacy and safety of bi-daily combination therapy with pyridoxine and doxylamine for nausea and vomiting of pregnancy. Isr Med Assoc J 2013;15:23-6. 6. Nguyen P, Einarson A. Managing nausea and vomiting of pregnancy with pharmacological and nonpharmacological treatments. Womens Health (Lond) 2006;2:753-60. [ DOI:10.2217/17455057.2.5.763] 7. Nuangchamnong N, Niebyl J. Doxylamine succinate-pyridoxine hydrochloride (Diclegis) for the management of nausea and vomiting in pregnancy: an overview. Int J Womens Health 2014;6:401-9. [ DOI:10.2147/IJWH.S46653] 8. Niebyl JR. Clinical practice. Nausea and vomiting in pregnancy. N Engl J Med 2010;363:1544-50. [ DOI:10.1056/NEJMcp1003896] 9. Firoz T, Maltepe C, Einarson A. Nausea and vomiting in pregnancy is not always nausea and vomiting of pregnancy. J Obstet Gynaecol Can 2010;32:970-2. [ DOI:10.1016/S1701-2163(16)34685-0] 10. Semmens JP. Female sexuality and life situations. An etiologic psycho-socio-sexual profile of weight gain and nausea and vomiting in pregnancy. Obstet Gynecol 1971;38:555-63. [ DOI:10.1097/00006250-197110000-00009] 11. Persaud N, Meaney C, El-Emam K, Moineddin R, Thorpe K. Doxylamine-pyridoxine for nausea and vomiting of pregnancy randomized placebo controlled trial: Prespecified analyses and reanalysis. PLoS One 2018 17;13:e0189978. [ DOI:10.1371/journal.pone.0189978] 12. Lacasse A, Rey E, Ferreira E, Morin C, Bérard A. Epidemiology of nausea and vomiting of pregnancy: prevalence, severity, determinants, and the importance of race/ethnicity. BMC Pregnancy Childbirth 2009;9:26. [ DOI:10.1186/1471-2393-9-26] 13. Andrews PLR, Williams RSB, Sanger GJ. Anti-emetic effects of thalidomide: Evidence, mechanism of action, and future directions. Curr Res Pharmacol Drug Discov 2022;3:100138. [ DOI:10.1016/j.crphar.2022.100138] 14. Collete DM, Aulton MD, Eds. Pharmaceutical Practice.5rd ed. New Yourk: Churchill Livingstone; 1990. P.145-56. 15. Bankers GS, NR. Tablets. In: Lachman L, Lieberman HA, Kanig JL, Eds. The Theory and Practice of Industrial Pharmacy. Bombay: Varghese Publishing House; 1987. P.296-302. 16. Lachman L, Lieberman HA, Kanig JL, Eds. The Theory and Practice of Industrial Pharmacy. Bombay: Varghese Publishing House; 1987. P.329-35.
|
